Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsector:
Natural Compounds
Indication:
Neoplasms / cancer / oncology
Products
In development: 1
Description:
KinSea Lead Discovery AS (KinSea) is a biotechnology start-up company developing marine bioactive compounds into pharmaceutically active products.
The lead program is a pan-mutant FMS-like tyrosine kinase 3 (FLT3) inhibitor, based on a natural product from the Arctic Ocean. These compounds are being studied for the treatment of acute myeloid leukemia (AML) as well as other hematologic tumors.
